妊娠期疑似肺栓塞评估指南比较:成本效果分析
该研究构建复杂马尔可夫决策模型,从美国医疗系统视角、终身时间 horizon,比较6个国际学会指南对妊娠期疑似肺栓塞诊断的成本效果,模型涵盖风险分层、经验性治疗、诊断检测策略、低分子肝素治疗及先进影像辐射暴露的短期和长期效应。基础案例分析显示ATS-STR指南健康获益最高(22.90 QALYs),相对ASTH-SOMANZ指南的ICER为7,808美元/QALY,具有成本效果;其余指南均被支配。ATS-STR指南策略较ASTH-SOMANZ每评估100例患者预期额外获得2.7 QALYs,结论对敏感性分析稳健,概率敏感性分析中86%场景最优。
要点
- ATS-STR指南健康获益最高(22.90 QALYs),相对ASTH-SOMANZ的ICER为7,808美元/QALY,低于意愿支付阈值100,000美元/QALY。
- ATS-STR指南策略较ASTH-SOMANZ每评估100例患者预期额外获得2.7 QALYs。
- 其余国际学会指南均被支配(健康获益更低且成本更高)。
- 概率敏感性分析中ATS-STR指南在86%场景下最优,结论对敏感性分析稳健。
适用人群与场景
- 妊娠期疑似肺栓塞的评估人群。
研究设计与关键结果
- 研究类型:成本效果分析,构建复杂马尔可夫决策模型,从美国医疗系统视角、终身时间 horizon,比较6个国际学会指南对妊娠期疑似肺栓塞的诊断策略。
- 模型涵盖风险分层、经验性治疗、诊断检测策略、低分子肝素治疗及先进影像辐射暴露的短期和长期效应;临床效果以时间贴现的质量调整生命年(QALYs)衡量,成本以美元衡量。
- 基础案例分析:ATS-STR指南健康获益最高(22.90 QALYs),相对ASTH-SOMANZ指南的ICER为7,808美元/QALY,意愿支付阈值100,000美元/QALY,具有成本效果;其余指南均被支配。
- ATS-STR指南策略较ASTH-SOMANZ每评估100例患者预期额外获得2.7 QALYs。
- 概率敏感性分析中ATS-STR指南在86%场景下最优,结论对敏感性分析稳健。
证据类型、等级与局限
- 证据类型:成本效果分析(基于决策模型)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,对于妊娠期疑似肺栓塞的诊断,ATS-STR指南具有成本效果,且较其他医学学会指南产生更好的预期健康结局。
指南或共识出处
- 美国胸科学会与胸部放射学会(ATS-STR)指南;澳大利亚血栓与止血学会及澳大利亚和新西兰产科医学学会(ASTH-SOMANZ)指南;共识别6个国际学会级指南。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Pulmonary embolism (PE) remains a leading cause of maternal mortality, yet diagnosis remains challenging. International diagnostic guidelines vary significantly in their recommendations, making it difficult to determine an optimal policy for evaluation.
RESEARCH QUESTION: Which societal-level diagnostic guidelines for evaluation of suspected PE in pregnancy are an optimal policy in terms of its cost-effectiveness?
STUDY DESIGN AND METHODS: We constructed a complex Markov decision model to evaluate the cost-effectiveness of each identified societal guidelines for diagnosis of PE in pregnancy. Our model accounted for risk stratification, empiric treatment, diagnostic testing strategies, as well as short- and long-term effects from PE, treatment with low-molecular-weight heparin, and radiation exposure from advanced imaging. We considered clinical and cost outcomes of each guideline from a US health care system perspective with a lifetime horizon. Clinical effectiveness and costs were measured in time-discounted quality-adjusted life years (QALYs) and US dollars, respectively. Strategies were compared using the incremental cost-effectiveness ratio (ICER) with a willingness-to-pay threshold of $100,000/QALY. One-way, multiway, and probabilistic sensitivity analyses were performed.
RESULTS: We identified six international societal-level guidelines. Base-case analysis showed the guideline proposed by the American Thoracic Society and Society of Thoracic Radiology (ATS-STR) yielded the highest health benefits (22.90 QALYs) and was cost-effective, with an ICER of $7,808 over the guidelines proposed by the Australian Society of Thrombosis and Haemostasis and the Society of Obstetric Medicine of Australia and New Zealand (ASTH-SOMANZ). All remaining guidelines were dominated. The ATS-STR guideline-recommended strategy yielded an expected additional 2.7 QALYs/100 patients evaluated over the ASTH-SOMANZ. Conclusions were robust to sensitivity analyses, with the ATS-STR guidelines optimal in 86% of probabilistic sensitivity analysis scenarios.
INTERPRETATION: The ATS-STR guidelines for diagnosis of suspected PE in pregnancy are cost-effective and generate better expected health outcomes than guidelines proposed by other medical societies.
参考来源
- McCandlish JA, Feizullayeva C, Spyropoulos AC, et al. Comparison of Guidelines for Evaluation of Suspected Pulmonary Embolism in Pregnancy: A Cost-effectiveness Analysis. Chest. 2021. PMID: 34914975. doi:10.1016/j.chest.2021.11.036
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。